Jump to Content Jump to Main Navigation

Volume 14 (2016): Issue 9 (Sep 2016)

in Journal of the National Comprehensive Cancer Network

Online ISSN:: 1540-1413

Print ISSN:: 1540-1405

Cover Journal of the National Comprehensive Cancer Network

NCCN News

Pages: xvii–xxii
Oncology Research Program

Pages: xxiv
Hillary and Donald, Our Patients Are Watching

By: Margaret Tempero

Pages: 1047
Allogeneic Hematopoietic Cell Transplantation for AML—A Missed Opportunity!

By: Margaret R. O'Donnell

Pages: 1052–1053
Characterization of Prostate Cancer in a Functional Eunuch

By: John J. Stocking, Michael V. Fiandalo, Elena A. Pop, John H. Wilton, Gissou Azabdaftari and James L. Mohler

Pages: 1054–1060
NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016

By: Steven M. Horwitz, Andrew D. Zelenetz, Leo I. Gordon, William G. Wierda, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis, Nancy Bartlett, John C. Byrd, Luis E. Fayad, Richard I. Fisher, Martha J. Glenn, Thomas M. Habermann, Nancy Lee Harris, Francisco Hernandez-Ilizaliturri, Richard T. Hoppe, Mark S. Kaminski, Christopher R. Kelsey, Youn H. Kim, Susan Krivacic, Ann S. LaCasce, Matthew Lunning, Auayporn Nademanee, Oliver Press, Rachel Rabinovitch, Nishitha Reddy, Erin Reid, Kenneth Roberts, Ayman A. Saad, Lubomir Sokol, Lode J. Swinnen, Julie M. Vose, Joachim Yahalom, Nadeem Zafar, Mary Dwyer, Hema Sundar and Pierluigi Porcu

Pages: 1067–1079
Predictors of Antiestrogen Recommendation in Women With Estrogen Receptor–Positive Ductal Carcinoma In Situ

By: Rondi M. Kauffmann, Leanne Goldstein, Emily Marcinkowski, George Somlo, Yuan Yuan, Philip H.G. Ituarte, Laura Kruper, Leslie Taylor and Courtney Vito

Pages: 1081–1090
Current Status of Distress Screening in Designated Cancer Hospitals: A Cross-Sectional Nationwide Survey in Japan

By: Toru Okuyama, Yoshiyuki Kizawa, Tatsuya Morita, Hiroya Kinoshita, Megumi Uchida, Asami Shimada, Akemi Shirado Naito and Tatsuo Akechi

Pages: 1098–1104
The Population Benefit of Radiotherapy for Malignant Brain Tumors: Local Control and Survival Estimates for Guideline-Based Use

By: Timothy Paul Hanna, Geoffrey Paul Delaney and Michael Bernard Barton

Pages: 1111–1119
Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell Lymphoma

By: Adam J. Olszewski, Kalyan C. Mantripragada and Jorge J. Castillo

Pages: 1121–1129
Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology

By: Robert J. Morgan Jr, Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Kian Behbakht, Lee-may Chen, Larry Copeland, Marta Ann Crispens, Maria DeRosa, Oliver Dorigo, David M. Gershenson, Heidi J. Gray, Ardeshir Hakam, Laura J. Havrilesky, Carolyn Johnston, Shashikant Lele, Lainie Martin, Ursula A. Matulonis, David M. O'Malley, Richard T. Penson, Sanja Percac-Lima, Mario Pineda, Steven C. Plaxe, Matthew A. Powell, Elena Ratner, Steven W. Remmenga, Peter G. Rose, Paul Sabbatini, Joseph T. Santoso, Theresa L. Werner, Jennifer Burns and Miranda Hughes

Pages: 1134–1163
Next-Generation Sequencing: Role in Gynecologic Cancers

By: Tarra Evans and Ursula Matulonis

Pages: 1165–1173
Principles of Treatment for Borderline, Micropapillary Serous, and Low-Grade Ovarian Cancer

By: Kari E. Hacker, Shitanshu Uppal and Carolyn Johnston

Pages: 1175–1182
Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center

By: Harrys A. Torres, Lillian R. Roach, Parag Mahale, Minas P. Economides, Boris Blechacz, Ethan Miller, Roy Borchardt, Anis Rashid, Thein H. Oo, Bhavarth Shukla, Malik Farida, Charles D. Ericsson, Bruno P. Granwehr and Issam I. Raad

Pages: 1185–1188